19211997 17447256 11731016 11955478 15482632 18987557 27103462 17459426 18339632 26726927 19969013 17188889 16539676 12902997 22712725 22107703 23467277 23580201 11923423 25138642 30957546 23336047 18173840 14681910 11803442 17266593 25546305 1621311 - Search Results

Year	Number of Results
2000	5
2001	16
2002	30
2003	25
2004	24
2005	22
2006	27
2007	27
2008	22
2009	14
2010	19
2011	18
2012	10
2013	16
2014	8
2015	17
2016	16
2017	14
2018	6
2019	4
2020	7
2021	10
2022	5
2023	0

1

Effect of two behavioral tests on corticosterone level in plasma of mice lacking the noradrenaline transporter.

Solich J, Pałach P, Budziszewska B, Dziedzicka-Wasylewska M. Solich J, et al. Pharmacol Rep. 2008 Nov-Dec;60(6):1008-13. Pharmacol Rep. 2008. PMID: 19211997 Free article.

2

Increased dopamine D2High receptors in knockouts of the dopamine transporter and the vesicular monoamine transporter may contribute to spontaneous hyperactivity and dopamine supersensitivity.

Seeman P, Hall FS, Uhl G. Seeman P, et al. Synapse. 2007 Jul;61(7):573-6. doi: 10.1002/syn.20402. Synapse. 2007. PMID: 17447256 No abstract available.

3

Expression of catecholaminergic mRNAs in the hyperactive mouse mutant coloboma.

Jones MD, Williams ME, Hess EJ. Jones MD, et al. Brain Res Mol Brain Res. 2001 Nov 30;96(1-2):114-21. doi: 10.1016/s0169-328x(01)00281-9. Brain Res Mol Brain Res. 2001. PMID: 11731016

4

Identification and functional characterization of the novel isoforms of bovine norepinephrine transporter produced by alternative splicing.

Kitayama S, Kumagai K, Morita K, Dohi T. Kitayama S, et al. Brain Res. 2002 May 3;934(2):152-6. doi: 10.1016/s0006-8993(02)02417-4. Brain Res. 2002. PMID: 11955478

5

The many faces of fatigue in major depressive disorder.

Demyttenaere K, De Fruyt J, Stahl SM. Demyttenaere K, et al. Int J Neuropsychopharmacol. 2005 Mar;8(1):93-105. doi: 10.1017/S1461145704004729. Epub 2004 Oct 14. Int J Neuropsychopharmacol. 2005. PMID: 15482632 Free article. Review.

6

Cocaine does not produce reward in absence of dopamine transporter inhibition.

Tilley MR, O'Neill B, Han DD, Gu HH. Tilley MR, et al. Neuroreport. 2009 Jan 7;20(1):9-12. doi: 10.1097/WNR.0b013e32831b9ce4. Neuroreport. 2009. PMID: 18987557 Free PMC article.

7

Clinical and neurobiological factors in the management of treatment refractory attention-deficit hyperactivity disorder.

Shim SH, Yoon HJ, Bak J, Hahn SW, Kim YK. Shim SH, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Oct 3;70:237-44. doi: 10.1016/j.pnpbp.2016.04.007. Epub 2016 Apr 19. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 27103462 Review.

8

Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.

John CE, Jones SR. John CE, et al. Neuropharmacology. 2007 Jun;52(8):1596-605. doi: 10.1016/j.neuropharm.2007.03.004. Epub 2007 Mar 16. Neuropharmacology. 2007. PMID: 17459426 Free PMC article.

9

A regulatory domain in the N terminus of tryptophan hydroxylase 2 controls enzyme expression.

Murphy KL, Zhang X, Gainetdinov RR, Beaulieu JM, Caron MG. Murphy KL, et al. J Biol Chem. 2008 May 9;283(19):13216-24. doi: 10.1074/jbc.M706749200. Epub 2008 Mar 13. J Biol Chem. 2008. PMID: 18339632 Free PMC article.

10

Effects of oxytocin on adreno-medullary catecholamine synthesis, uptake and storage in rats exposed to chronic isolation stress.

Jovanovic P, Stefanovic B, Spasojevic N, Puskas N, Dronjak S. Jovanovic P, et al. Endocr Res. 2016 May;41(2):124-31. doi: 10.3109/07435800.2015.1094086. Epub 2016 Jan 4. Endocr Res. 2016. PMID: 26726927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results